The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Cyclooxygenase-2—10 Years Later
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,154
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., iyashiro, J. M., Penning, T. D., Seibert, K., et al. (1996) · Nature · doi:10.1038/384644a0 · Cited by 1,917
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., & Simmons, D. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2692 · Cited by 1,707
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Samad, T. A., Moore, K. A., Sapirstein, A., Billet, S., Allchorne, A., Poole, S., Bonventre, J. V., & Woolf, C. J. (2001) · Nature · doi:10.1038/35068566 · Cited by 1,281
Risk of Alzheimer's disease and duration of NSAID use
Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. (1997) · Neurology · doi:10.1212/wnl.48.3.626 · Cited by 1,132
The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.
Fu, J. Y., Masferrer, J. L., Seibert, K., Raz, A., & Needleman, P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44821-6 · Cited by 944
Kawamori, T., Rao, C. V., Seibert, K., & Reddy, B. S. (1998) · PubMed · Cited by 916
Harris, R. C., McKanna, J. A., Akai, Y., Jacobson, H. R., Dubois, R. N., & Breyer, M. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117620 · Cited by 860
Topper, J. N., Cai, J., Falb, D., & Gimbrone, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10417 · Cited by 843
Jones, M. K., Wang, H., Peskar, B. M., Levin, E., Itani, R. M., Sarfeh, I. J., & Tarnawski, A. S. (1999) · Nature Medicine · doi:10.1038/70995 · Cited by 827
Lee, S. H., Soyoola, E., Chanmugam, P., Hart, S., Sun, W., Zhong, H., Liou, S., Simmons, D., & Hwang, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35698-9 · Cited by 811
Pharmacological analysis of cyclooxygenase-1 in inflammation
Smith, C. J., Zhang, Y., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Shaffer, A., Talley, J. J., Masferrer, J. L., Seibert, K., & Isakson, P. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13313 · Cited by 807
Adverse Upper Gastrointestinal Effects of Rofecoxib Compared With NSAIDs
Langman, M. J. (1999) · JAMA · doi:10.1001/jama.282.20.1929 · Cited by 686
Mizuno, H., Sakamoto, C., Matsuda, K., Wada, K., Uchida, T., Noguchi, H., Akamatsu, T., & Kasuga, M. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024292 · Cited by 637
Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2
Luong, C., Miller, A., Barnett, J., Chow, J., Ramesha, C., & Browner, M. F. (1996) · Nature Structural Biology · doi:10.1038/nsb1196-927 · Cited by 618
Catella-Lawson, F., McAdam, B., Morrison, B. W., Kapoor, S., Kujubu, D., Antes, L., Lasseter, K. C., Quan, H., Gertz, B. J., & Fitzgerald, G. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 597
Structure of the human cyclo-oxygenase-2 gene
Appleby, S. B., Ristimäki, A., Neilson, K., Narko, K., & Hla, T. (1994) · Biochemical Journal · doi:10.1042/bj3020723 · Cited by 479
Cyclooxygenase-2 and carcinogenesis
Prescott, S. M., & Fitzpatrick, F. A. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00006-8 · Cited by 476
Riendeau, D., Percival, M. D., Brideau, C., Charleson, S., Dubé, D., Ethier, D., Falgueyret, J.-P., Friesen, R. W., Gordon, R., Greig, G., et al. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38776-2 · Cited by 460
FU, S., RAMANUJAM, K., WONG, A., FANTRY, G., DRACHENBERG, C., JAMES, S., MELTZER, S., & WILSON, K. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70496-8 · Cited by 408
Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa
Whittle, B. J. R., Higgs, G. A., Eakins, K. E., Moncada, S., & Vane, J. R. (1980) · Nature · doi:10.1038/284271a0 · Cited by 392
Leese, P. T., Hubbard, R. C., Karim, A., Isakson, P. C., Yu, S. S., & Geis, G. S. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022008766 · Cited by 371
Anovulation in Cyclooxygenase-2-Deficient Mice Is Restored by Prostaglandin E2 and Interleukin-1β*
Davis, B. J., Lennard, D. E., Lee, C. A., Tiano, H. F., Morham, S. G., Wetsel, W. C., & Langenbach, R. (1999) · Endocrinology · doi:10.1210/endo.140.6.6715 · Cited by 352
Post-transcriptional Control of Cyclooxygenase-2 Gene Expression
Dixon, D. A., Kaplan, C. D., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.11750 · Cited by 349
Chakraborty, I., Das, S. K., Wang, J., & Dey, S. K. (1996) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0160107 · Cited by 338
Distribution and regulation of cyclooxygenase‐2 in carrageenan‐induced inflammation
Nantel, F., Denis, D., Gordon, R., Northey, A., Cirino, M., Metters, K. M., & Chan, C. C. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702866 · Cited by 333
Up‐regulation of cyclooxygenase‐2 mRNA in the rat spinal cord following peripheral inflammation
Beiche, F., Scheuerer, S., Brune, K., Geisslinger, G., & Goppelt-Struebe, M. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00604-7 · Cited by 329
Self-citationAllgemeine und spezielle Pharmakologie und Toxikologie
Oberdisse, E. (1983) · Springer eBooks · doi:10.1007/978-3-642-69018-1 · Cited by 325
EHRICH, E., DALLOB, A., DELEPELEIRE, I., VANHECKEN, A., RIENDEAU, D., YUAN, W., PORRAS, A., WITTREICH, J., SEIBOLD, J., & DESCHEPPER, P. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70113-x · Cited by 322
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
ROSSAT, J., MAILLARD, M., NUSSBERGER, J., BRUNNER, H., & BURNIER, M. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70056-1 · Cited by 318
Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate
Xu, X.-M., Sansores-Garcia, L., Chen, X.-M., Matijevic-Aleksic, N., Du, M., & Wu, K. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5292 · Cited by 301
Schmassmann, A., Peskar, B. M., Stettler, C., Netzer, P., Stroff, T., Flogerzi, B., & Halter, F. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701672 · Cited by 287
Renal Effects of COX-2-Selective Inhibitors
Brater, D. C., Harris, C., Redfern, J. S., & Gertz, B. J. (2001) · American Journal of Nephrology · doi:10.1159/000046212 · Cited by 265
Aspirin-like Molecules that Covalently Inactivate Cyclooxygenase-2
Kalgutkar, A. S., Crews, B. C., Rowlinson, S. W., Garner, C., Seibert, K., & Marnett, L. J. (1998) · Science · doi:10.1126/science.280.5367.1268 · Cited by 258
Kalgutkar, A. S., Crews, B. C., Rowlinson, S. W., Marnett, A. B., Kozak, K. R., Remmel, R. P., & Marnett, L. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.925 · Cited by 252
Langenbach, R., Loftin, C., Lee, C., & Tiano, H. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00158-6 · Cited by 230
Direct Activation of Rat Spinal Dorsal Horn Neurons by Prostaglandin E2
Baba, H., Kohno, T., Moore, K. A., & Woolf, C. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01750.2001 · Cited by 228
Loftin, C. D., Trivedi, D. B., Tiano, H. F., Clark, J. A., Lee, C. A., Epstein, J. A., Morham, S. G., Breyer, M. D., Nguyen, M., Hawkins, B. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1059 · Cited by 219
Praticò, D., Tillmann, C., Zhang, Z.-B., Li, H., & FitzGerald, G. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061607398 · Cited by 215
Onoe, Y., Miyaura, C., Kaminakayashiki, T., Nagai, Y., Noguchi, K., Chen, Q. R., Seo, H., Ohta, H., Nozawa, S., Kudo, I., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.2.758 · Cited by 211
Kraemer, S. A., Meade, E. A., & DeWitt, D. L. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90411-o · Cited by 208
Cyclooxygenase 2 inhibitors: discovery, selectivity and the future
Marnett, L. J., & Kalgutkar, A. S. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01385-1 · Cited by 205
(2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00861.x · Cited by 187
Renal Safety and Tolerability of Celecoxib, a Novel Cyclooxygenase-2 Inhibitor
Whelton, A., Maurath, C. J., Verburg, K. M., & Geis, G. S. (2000) · American Journal of Therapeutics · doi:10.1097/00045391-200007030-00004 · Cited by 167
Regulation by Interleukin-10 and Interleukin-4 of Cyclooxygenase-2 Expression in Human Neutrophils
Niiro, H., Otsuka, T., Izuhara, K., Yamaoka, K., Ohshima, K., Tanabe, T., Hara, S., Nemoto, Y., Tanaka, Y., Nakashima, H., et al. (1997) · Blood · doi:10.1182/blood.v89.5.1621 · Cited by 167
Cyclooxygenase-2–selective inhibitors impair glomerulogenesis and renal cortical development
Kömhoff, M., Wang, J.-L., Cheng, H.-F., Langenbach, R., Mckanna, J. A., Harris, R. C., & Breyer, M. D. (2000) · Kidney International · doi:10.1016/s0085-2538(15)46757-2 · Cited by 165
Expression of cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy
Slater, D. M., Dennes, W. J. B., Campa, J. S., Poston, L., & Bennett, P. R. (1999) · MHR: Basic science of reproductive medicine · doi:10.1093/molehr/5.9.880 · Cited by 161
Crofford, L. J., Oates, J. C., McCune, W. J., Gupta, S., Kaplan, M. J., Catella-Lawson, F., Morrow, J. D., McDonagh, K. T., & Schmaier, A. H. (2000) · Arthritis & Rheumatism · Cited by 152
Ehrich, E. W., Schnitzer, T. J., McIlwain, H. H., Levy, R. M., Wolfe, F., Weisman, M. H., Zeng, Q., Morrison, B. W., Bolognese, J., Seidenberg, B. C., et al. (1999) · PubMed · Cited by 146
Traynor, T. R., Smart, A., Briggs, J. P., & Schnermann, J. B. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.5.f706 · Cited by 126
Hinz, B., Brune, K., & Pahl, A. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2859 · Cited by 123
Self-citationImmunolocalization of cyclooxygenase‐2 in the macula densa of human elderly
Nantel, F., Meadows, E., Denis, D., Connolly, B., Metters, K. M., & Giaid, A. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01088-1 · Cited by 121
Constitutive Cyclooxygenase-2 Expression in Healthy Human and Rabbit Gastric Mucosa
Zimmermann, K. C., Sarbia, M., Schrör, K., & Weber, A. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.3.536 · Cited by 121
Minghetti, L., Polazzi, E., Nicolini, A., Créminon, C., & Levi, G. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01444.x · Cited by 111
Hinz, B., Brune, K., & Pahl, A. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3885 · Cited by 102
Self-citationMaldve, R. E., Kim, Y., Muga, S. J., & Fischer, S. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32029-0 · Cited by 96
Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes
Maihöfner, C., Schlötzer-Schrehardt, U., Gühring, H., et al. (2001) · PubMed · doi:10.5167/uzh-5516 · Cited by 96
Pasinetti, G. M. (2001) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(01)00091-7 · Cited by 92
Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine.
Zembowicz, A., Jones, S. L., & Wu, K. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118211 · Cited by 90
Gibb, W., & Sun, M. (1996) · Journal of Endocrinology · doi:10.1677/joe.0.1500497 · Cited by 81
Preston, S., Arnold, M. H., Beller, E., Brooks, P., & Buchanan, W. W. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03423.x · Cited by 74
Sawdy, R., Slater, D. M., Dennes, W., Sullivan, M. H. F., & Bennett, P. R. (2000) · Placenta · doi:10.1053/plac.1999.0438 · Cited by 59
Aspirin-like molecules that covalently inactivate cyclooxygenase-2
Kalgutkar, A. S. S., Crews, B. C., Rowlinson, S. W., Garner, C., Seibert, K., Marnett, L. J., & Kresge, A. J. (1999) · Cited by 58
Harris, Chêng, Wang, Zhang, & McKanna (2000) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2000.00642.x · Cited by 34
Cited by
Caught up in a Wnt storm: Wnt signaling in cancer
Giles, R. H., van Es, J. H., & Clevers, H. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00005-2 · Cited by 1,482
Carbaboranes as Pharmacophores: Properties, Synthesis, and Application Strategies
Scholz, M., & Hey-Hawkins, E. (2011) · Chemical Reviews · doi:10.1021/cr200038x · Cited by 797
Cyclooxygenase-2 (COX-2) in Inflammatory and Degenerative Brain Diseases
Minghetti, L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.901 · Cited by 779
Pharmacological significance of triazole scaffold
Kharb, R., Sharma, P. C., & Yar, M. S. (2011) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756360903524304 · Cited by 598
Anti-Inflammatory Treatments for Chronic Diseases: A Review
Laveti, D., Kumar, M., Hemalatha, R., Sistla, R., Naidu, V., Talla, V., Verma, V., Kaur, N., & Nagpal, R. (2013) · Inflammation & Allergy-Drug Targets · doi:10.2174/18715281113129990053 · Cited by 325
Metadata
- Authors
- Hinz, B., & Brune, K.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 300
- Issue
- 2
- Pages
- 367-375
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2089288753
- Cited by
- 518
- References
- 69
- FWCI
- 16.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.